about
Role of Dendritic Cells in the Induction of Lymphocyte TolerancePros and Cons of Antigen-Presenting Cell Targeted Tumor VaccinesTheranostic mRNA-loaded microbubbles in the lymphatics of dogs: implications for drug delivery.Harnessing Human Cross-Presenting CLEC9A(+)XCR1(+) Dendritic Cells for Immunotherapy.Optimizing dendritic cell-based approaches for cancer immunotherapyAntigen targeting to dendritic cells combined with transient regulatory T cell inhibition results in long-term tumor regressionNew generation of dendritic cell vaccines.Antigen cross-presentation of immune complexes.Targeting BCL2 family in human myeloid dendritic cells: a challenge to cure diseases with chronic inflammations associated with bone loss.New approaches to transcutaneous immunotherapy: targeting dendritic cells with novel allergen conjugates.Dendritic cells in atherosclerotic inflammation: the complexity of functions and the peculiarities of pathophysiological effectsDendritic cell-based immunotherapy: a basic review and recent advances.Enhanced Humoral Responses Induced by Targeting of Antigen to Murine Dendritic Cells.Antigen targeting reveals splenic CD169+ macrophages as promoters of germinal center B-cell responses.Antibodies targeting Clec9A promote strong humoral immunity without adjuvant in mice and non-human primates.Human skin dendritic cells can be targeted in situ by intradermal injection of antibodies against lectin receptors.Glycan-based DC-SIGN targeting to enhance antigen cross-presentation in anticancer vaccines.Dendritic cell science: more than 40 years of history.A Rift Valley fever virus Gn ectodomain-based DNA vaccine induces a partial protection not improved by APC targeting.Targeting Dendritic Cells: The Role of Specific Receptors in the Internalization of Polymer CapsulesOptimization of the Linker Length of Mannose-Cholesterol Conjugates for Enhanced mRNA Delivery to Dendritic Cells by Liposomes
P2860
Q26779405-2F3601C6-4AF1-4469-B70D-6242B888BEDDQ27013679-45EF466F-2A7B-4CD2-83FB-00EBD2F3B1E4Q30422136-FF12E89A-D0BA-4B0F-B82F-DF334C98EDCAQ33659782-7C054B29-4FD8-4270-8507-6C60A46F4833Q34637535-A78D21FD-4174-4EB1-A304-A9C4321917DAQ36060263-E5D51962-3D14-4A99-9B17-52C11E156C71Q37384717-09C41879-B930-4706-BBA4-171AA217D73BQ37689507-EA2F25D9-19E2-4A3C-8CFA-51A6CBCEE3DAQ38114069-B807799A-F8B6-4474-AE36-D3E909C09891Q38156306-C18A5D66-C9FA-4974-B37C-2D3A476E5093Q38218096-E50D02EA-2D00-4F5F-808D-563BA697BBE9Q38665350-0A6AC17E-E118-494E-ABDB-ED5D7F1DFEEBQ40565323-1B89E642-E66D-49DF-A85A-7FAAE0100BCEQ40593868-A65F26B7-B57E-4971-8354-9CF53670BDDCQ41610389-3347B90F-3A70-4913-8B32-A0BF650A495CQ42106951-41123946-3919-4FFE-A7B5-EA5F86F12590Q43225868-DBB33F45-FFF2-49FD-B7A2-F4C0078BB662Q44394211-39C21436-2DCF-48C0-857D-6359FB3F8076Q54942043-E6C16A7D-432A-4D64-92CB-A02093D7CB6CQ57644957-940E1C83-EE44-437B-9B3B-FBA41D56167AQ58762847-06CED0D9-DD6F-43F6-A190-ECD6B8017F9E
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Targeting Dendritic Cells in vivo for Cancer Therapy.
@ast
Targeting Dendritic Cells in vivo for Cancer Therapy.
@en
type
label
Targeting Dendritic Cells in vivo for Cancer Therapy.
@ast
Targeting Dendritic Cells in vivo for Cancer Therapy.
@en
prefLabel
Targeting Dendritic Cells in vivo for Cancer Therapy.
@ast
Targeting Dendritic Cells in vivo for Cancer Therapy.
@en
P2860
P356
P1476
Targeting Dendritic Cells in vivo for Cancer Therapy.
@en
P2093
Eugene Maraskovsky
P2860
P356
10.3389/FIMMU.2012.00013
P577
2012-02-07T00:00:00Z